Applying Engineering Perspective to Biology at Scribe Therapeutics

Ben Oakes, co-founder and CEO of Scribe Therapeutics, discusses their approach of applying engineering to biology. By starting with the engineering perspective, they can avoid the limitations and challenges of using existing molecules and instead focus on building better versions for genome editing. This approach allows them to make genome editing more potent, safer, and more deliverable, with the goal of transforming genetic medicine to prevent diseases rather than just treat them.